PROLLENIUM® Launches VAMPTM Advanced, a Patent-Pending PDRN Solution

AI Briefing

• – Prolenium launches VAMPTM Advanced, a PDRN solution with patent pending, addressing tissue regeneration and musculoskeletal disorders.
• – The VAMPTM technology utilizes a proprietary blend of biologics and scaffolding to promote tissue regeneration.
• – VAMPTM Advanced is designed to provide a novel, long-term solution for musculoskeletal disorders and injuries.